Inventor
Daniel Gudbjartsson
Inventor
Reykjavik, IS
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Qprimary
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms40%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology20%
A61BDiagnosis10%
Y02ATechnologies for adaptation to climate change10%
PatentTitleYear
8,795,963'Genetic markers for risk management of atrial fibrillation and stroke'20148,796,182'Genetic markers associated with risk of diabetes mellitus'20148,637,244'Genetic markers for risk management of atrial fibrillation, atrial flutter, and stroke'20148,367,333'Genetic variants as markers for use in diagnosis, prognosis and treatment of eosinophilia, asthma, and myocardial infarction'2013Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2013–2014Patents assigned to DECODE GENETICS EHF (4)· patent assignee history
2013–2014Patents assigned to GUDBJARTSSON DANIEL (4)· patent assignee history
2013Patents assigned to BJORNSDOTTIR UNNUR S (1)· patent assignee history
2013–2014Based in ReykjavÃk, IS· patent location history
2014Patents assigned to HELGADOTTIR ANNA (1)· patent assignee history
2014Patents assigned to HOLM HILMA (1)· patent assignee history
2014Based in Reykjavik, IS· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| DECODE GENETICS EHF | 4 | 2013–2014 |
| GUDBJARTSSON DANIELself | 4 | 2013–2014 |
| BJORNSDOTTIR UNNUR S | 1 | 2013 |
| HELGADOTTIR ANNA | 1 | 2014 |
| HOLM HILMA | 1 | 2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Reykjavik, IS | 2 | 2014 |
| ReykjavÃk, IS | 2 | 2013–2014 |